Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

The timing of differentiation and potency of CD8 effector function is set by RNA binding proteins

Georg Petkau, Twm J. Mitchell, Krishnendu Chakraborty, View ORCID ProfileSarah E. Bell, Vanessa D’Angeli, View ORCID ProfileLouise Matheson, David J. Turner, View ORCID ProfileAlexander Saveliev, View ORCID ProfileOzge Gizlenci, View ORCID ProfileFiamma Salerno, View ORCID ProfilePeter D. Katsikis, View ORCID ProfileMartin Turner
doi: https://doi.org/10.1101/2021.06.03.446738
Georg Petkau
1Immunology Programme The Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Twm J. Mitchell
1Immunology Programme The Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Krishnendu Chakraborty
1Immunology Programme The Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah E. Bell
1Immunology Programme The Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sarah E. Bell
Vanessa D’Angeli
1Immunology Programme The Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louise Matheson
1Immunology Programme The Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Louise Matheson
David J. Turner
1Immunology Programme The Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Saveliev
1Immunology Programme The Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alexander Saveliev
Ozge Gizlenci
1Immunology Programme The Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ozge Gizlenci
Fiamma Salerno
1Immunology Programme The Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fiamma Salerno
Peter D. Katsikis
2Department of Immunology, Erasmus University Medical Center, P.O. Box 2040, 3000CA Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter D. Katsikis
Martin Turner
1Immunology Programme The Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martin Turner
  • For correspondence: martin.turner@babraham.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Abstract

CD8+ T cell differentiation into effector cells is initiated early after antigen encounter by signals from the T cell antigen receptor and costimulatory molecules. The molecular mechanisms that determine the timing and rate of differentiation however are not defined. Here we show that the RNA binding proteins (RBP) ZFP36 and ZFP36L1 limit the rate of differentiation of activated naïve CD8+ T cells and the potency of the resulting cytotoxic lymphocytes. The RBP act in an early and short temporal window to enforce dependency on costimulation via CD28 for full T cell activation and effector differentiation by directly binding mRNA of NF-ĸB, IRF8 and NOTCH1 transcription factors and cytokines, including IL2. Their absence in T cells, or the adoptive transfer of a small numbers of CD8+ T cells lacking the RBP, promotes resilience to influenza A virus infection without immunopathology. These findings highlight ZFP36 and ZFP36L1 as nodes for the integration of the early T cell activation signals determining the speed and quality of the CD8 response.

Competing Interest Statement

The authors have declared no competing interest.

Footnotes

  • Revised to include new data

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted March 14, 2022.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The timing of differentiation and potency of CD8 effector function is set by RNA binding proteins
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The timing of differentiation and potency of CD8 effector function is set by RNA binding proteins
Georg Petkau, Twm J. Mitchell, Krishnendu Chakraborty, Sarah E. Bell, Vanessa D’Angeli, Louise Matheson, David J. Turner, Alexander Saveliev, Ozge Gizlenci, Fiamma Salerno, Peter D. Katsikis, Martin Turner
bioRxiv 2021.06.03.446738; doi: https://doi.org/10.1101/2021.06.03.446738
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
The timing of differentiation and potency of CD8 effector function is set by RNA binding proteins
Georg Petkau, Twm J. Mitchell, Krishnendu Chakraborty, Sarah E. Bell, Vanessa D’Angeli, Louise Matheson, David J. Turner, Alexander Saveliev, Ozge Gizlenci, Fiamma Salerno, Peter D. Katsikis, Martin Turner
bioRxiv 2021.06.03.446738; doi: https://doi.org/10.1101/2021.06.03.446738

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Immunology
Subject Areas
All Articles
  • Animal Behavior and Cognition (3586)
  • Biochemistry (7545)
  • Bioengineering (5495)
  • Bioinformatics (20732)
  • Biophysics (10294)
  • Cancer Biology (7951)
  • Cell Biology (11611)
  • Clinical Trials (138)
  • Developmental Biology (6586)
  • Ecology (10168)
  • Epidemiology (2065)
  • Evolutionary Biology (13580)
  • Genetics (9521)
  • Genomics (12817)
  • Immunology (7906)
  • Microbiology (19503)
  • Molecular Biology (7641)
  • Neuroscience (41982)
  • Paleontology (307)
  • Pathology (1254)
  • Pharmacology and Toxicology (2192)
  • Physiology (3259)
  • Plant Biology (7025)
  • Scientific Communication and Education (1294)
  • Synthetic Biology (1947)
  • Systems Biology (5419)
  • Zoology (1113)